You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 11, November 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prednisone Therapy for Alopecia Areata

A Follow-Up Report

Robert J. Winter, MD; Frank Kern, MD; Robert M. Blizzard, MD

Arch Dermatol. 1976;112(11):1549-1552.


Abstract

• Eighteen patients treated with prednisone on alternate days for varying degrees of alopecia areata (AA) were examined a mean of 15 months after discontinuation of the drug. Despite an initial response to the therapy, long-term benefit was not thought to be substantial. Numerous side effects related either to systemic corticosteroids or to AA were apparent during the course of therapy, as well as at the time of the evaluation reported herein. Acne, obesity, lenticular opacities, mild hypertension, and impaired adrenocorticotropic hormone (ACTH) reserve were among the findings noted. Long-term treatment was not accompanied by an obvious beneficial change in the natural course of AA. Because of the potentially serious side effects and the lack of substantial improvement in the eventual course, alternate-day prednisone therapy is not recommended for long-term use in AA.

(Arch Dermatol 112:1549-1552, 1976)



Author Affiliations

From the Department of Pediatric Endocrinology (Drs Winter and Blizzard) and the Subdepartment of Dermatology (Dr Kern), Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Baltimore.


Footnotes

Accepted for publication Feb 9, 1976.

Reprint requests to Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614 (Dr Winter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
Olsen et al.
Arch Dermatol 1992;128:1467-1473.
ABSTRACT  

Alopecia Areata: A Review of Therapy, Efficacy, Safety, and Mechanism
Fiedler
Arch Dermatol 1992;128:1519-1529.
ABSTRACT  

Commentary: Cortisone Acetate Administered Orally in Dermatologic Therapy
Fine
Arch Dermatol 1983;119:865-868.
ABSTRACT  

Corticosteroids in the Treatment of Alopecia Totalis: Systemic Effects
Unger and Schemmer
Arch Dermatol 1978;114:1486-1490.
ABSTRACT  

Treatment of Alopecia Areata With Dinitrochlorobenzene
Daman et al.
Arch Dermatol 1978;114:1036-1038.
ABSTRACT  

Alopecia Areata and Regrowth of Hair-Reply
Winter et al.
Arch Dermatol 1977;113:1732-1733.
ABSTRACT  

Prednisone Therapy for Alopecia Areata
Unger
Arch Dermatol 1977;113:1457-1457.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.